Being Intouch

08/01/2026

https://www.facebook.com/share/p/1GccZW4FdC/

Send a message to learn more

08/01/2026

https://www.facebook.com/share/p/1D4Rmutu3n/

Send a message to learn more

05/01/2026

https://www.facebook.com/share/p/1Cpttdt6Pq/

Send a message to learn more

04/01/2026

https://www.facebook.com/share/p/1Eu3aW9X42/

Send a message to learn more

04/01/2026

https://www.facebook.com/share/p/14T7e8UbHk6/

Send a message to learn more

31/12/2025

https://www.facebook.com/share/p/1BmuXZSQNA/

Send a message to learn more

31/12/2025

https://www.facebook.com/share/p/1CvSfv1j3b/

Japanese biologist Yoshinori Ohsumi won the Nobel Prize for discovering how the body removes damaged cells when it doesn’t receive food. The process is called autophagy, and it’s how the body recycles its internal waste, breaking down old, malfunctioning cells and turning them into energy.

This natural system activates during fasting, when no external nutrients are available. Instead of shutting down, the body enters a powerful repair mode, cleaning itself from the inside out. It removes toxins, damaged proteins, and harmful cellular debris and uses those parts to rebuild new, healthier cells.

Autophagy has been linked to slowing aging, improving immunity, reducing inflammation, and even protecting the brain from disorders like Alzheimer’s and Parkinson’s. It’s now considered one of the most important mechanisms for long-term health.

This discovery has influenced modern health practices such as intermittent fasting, time-restricted eating, and extended fasts, all aiming to trigger this self-healing process. By cycling between feeding and fasting, the body maintains balance, renews itself, and reduces the risk of many chronic diseases.

The research also suggests that autophagy may help the body fight cancer, repair metabolic damage, and support longevity without relying on medication. It’s a clear reminder that sometimes giving the body less can do so much more.

31/12/2025

https://www.facebook.com/share/p/1ZpgxWnaAb/

Send a message to learn more

30/12/2025

https://www.facebook.com/share/p/1Cyg3vN6T6/

Send a message to learn more

28/12/2025

26/12/2025

https://www.facebook.com/share/p/1C2tywdRCg/

New Zealand researchers found ocean bacteria producing powerful new antibiotics. Marine biologists at the University of Auckland discovered bacteria living in deep-sea volcanic vents near Kermadec Trench that produce novel antimicrobial compounds effective against antibiotic-resistant superbugs. The organisms thrive in extreme conditions—near-boiling temperatures, crushing pressures, and toxic chemical environments—where they evolved unique defensive chemicals never before seen by science.

The bacteria produce molecules called kermamicins that kill methicillin-resistant Staphylococcus aureus (MRSA), drug-resistant tuberculosis, and carbapenem-resistant Enterobacteriaceae—three of the deadliest superbugs facing modern medicine. Laboratory testing shows kermamicins work by disrupting bacterial cell membranes in ways completely different from existing antibiotics, meaning bacteria haven't developed resistance mechanisms. The compounds remain stable at body temperature, don't harm human cells even at high concentrations, and break down naturally in the environment, making them ideal drug candidates.

Antibiotic resistance kills 1.27 million people annually, with projections suggesting 10 million deaths per year by 2050 if new antibiotics aren't developed. Pharmaceutical companies have largely abandoned antibiotic research because bacteria evolve resistance faster than companies can recoup development costs. Finding entirely new classes of antibiotics—especially from extreme environments where evolution favored different biochemical strategies—offers hope for staying ahead of resistant pathogens. The deep ocean, covering 65% of Earth's surface and hosting millions of unexplored species, represents an untapped pharmacy containing potentially thousands of medical breakthroughs.

The research team isolated and cultured the bacteria successfully, producing kermamicins in quantities sufficient for clinical trials beginning in 2026. Early toxicity studies in mice showed zero adverse effects at therapeutic doses. New Zealand's government has invested $12 million in deep-sea bioprospecting, recognizing that their territorial waters contain some of Earth's most extreme and biodiverse environments. Scientists estimate they've explored less than 1% of New Zealand's deep ocean ecosystems, suggesting hundreds more medicinal compounds await discovery. 🌊💊